SARS-CoV-2-related ARDS in a maintenance hemodialysis patient: case report on tailored approach by daily hemodialysis, noninvasive ventilation, tocilizumab, anxiolytics, and point-of-care ultrasound.
COVID‐19
expanded hemodialysis
hemodialysis
point‐of‐care ultrasound
suprahepatic veins venogram
tocilizumab
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
18
10
2020
revised:
16
11
2020
accepted:
18
11
2020
pubmed:
29
12
2020
medline:
29
12
2020
entrez:
28
12
2020
Statut:
epublish
Résumé
Without rescue drugs approved, holistic approach by daily hemodialysis, noninvasive ventilation, anti-inflammatory medications, fluid assessment by bedside ultrasound, and anxiolytics improved outcomes of a maintenance hemodialysis patient affected by severe COVID-19.
Identifiants
pubmed: 33362933
doi: 10.1002/ccr3.3623
pii: CCR33623
pmc: PMC7753751
doi:
Types de publication
Case Reports
Langues
eng
Pagination
694-703Informations de copyright
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
None declared.